Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 14, 2019; 25(46): 6713-6727
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6713
Published online Dec 14, 2019. doi: 10.3748/wjg.v25.i46.6713
Table 1 Relationship between expression levels of SPARC mRNA and clinicopathological characteristics, n (%)
| Parameters | Total, n = 66 | Expression level of SPARC gene | P value | |
| Low, n = 42 | High, n = 24 | |||
| Age in yr | ||||
| < 60 | 21 | 16 (76.2) | 5 (23.8) | 0.186 |
| ≥ 60 | 45 | 26 (57.8) | 19 (42.2) | |
| Gender | ||||
| Male | 51 | 32 (62.7) | 19 (37.3) | 0.348 |
| Female | 15 | 10 (66.7) | 5 (33.3) | |
| Size in cm | ||||
| < 5 | 27 | 18 (66.7) | 9 (33.3) | 0.372 |
| ≥ 5 | 39 | 24 (61.5) | 15 (38.4) | |
| Differentiation | ||||
| Good/moderate | 16 | 8 (50.0) | 8 (50.0) | 0.154 |
| Poor | 50 | 34 (68.0) | 16 (32.0) | |
| Location | ||||
| Upper | 8 | 3 (37.5) | 5 (62.5) | 0.759 |
| Middle | 18 | 8 (44.4) | 10 (56.6) | |
| Lower | 40 | 31 (77.5) | 9 (22.5) | |
| Macroscopic type | ||||
| Borrmann I + II | 19 | 6 (31.6) | 13 (68.4) | 0.015a |
| Borrmann III + IV | 47 | 36 (76.6) | 11 (23.4) | |
| TNM stage | ||||
| I + II | 27 | 7 (25.9) | 20 (74.1) | 0.001a |
| III + IV | 39 | 35 (89.8) | 4 (10.2) | |
| Lymph node metastasis | ||||
| - | 18 | 6 (33.3) | 12 (66.7) | 0.001a |
| + | 48 | 36 (75.0) | 12 (25.0) | |
Table 2 Relationship between methylation status of SPARC gene and clinicopathological characteristics, n (%)
| Parameters | Total, n = 66 | Methylation status of SPARC | P value | ||
| U, n = 19 | P, n = 11 | M, n = 36 | |||
| Age in yr | |||||
| < 60 | 21 | 6 (28.6) | 1 (4.8) | 14 (66.7) | 0.178 |
| ≥ 60 | 45 | 13 (28.9) | 10 (22.2) | 22 (48.9) | |
| Gender | |||||
| Male | 51 | 17 (33.3) | 8 (15.7) | 26 (51.0) | 0.323 |
| Female | 15 | 2 (13.3) | 3 (20.0) | 10 (66.7) | |
| Size in cm | |||||
| < 5 | 27 | 6 (22.2) | 6 (22.2) | 15 (55.6) | 0.463 |
| ≥ 5 | 39 | 13 (33.3) | 5 (12.8) | 21 (53.8) | |
| Differentiation | |||||
| Good/moderate | 16 | 6 (37.5) | 4 (25.0) | 6 (37.5) | 0.278 |
| Poor | 50 | 13 (26.0) | 7 (14.0) | 30 (60.0) | |
| Location | |||||
| Upper | 8 | 2 (25.0) | 3 (37.5) | 3 (37.5) | 0.297 |
| Middle | 18 | 6 (33.3) | 4 (22.2) | 8 (44.4) | |
| Lower | 40 | 11 (27.5) | 4 (10.0) | 25 (62.5) | |
| Macroscopic type | |||||
| Borrmann I + II | 19 | 9 (47.4) | 6 (31.6) | 4 (21.1) | 0.002a |
| Borrmann III + IV | 47 | 10 (21.3) | 5 (10.6) | 32 (68.1) | |
| TNM stage | |||||
| I + II | 27 | 14 (51.9) | 8 (29.6) | 5 (18.5) | 0.001a |
| III + IV | 39 | 5 (12.8) | 3 (7.7) | 31 (79.5) | |
| Lymph node metastasis | |||||
| - | 18 | 13 (72.2) | 2 (11.1) | 3 (16.7) | 0.001a |
| + | 48 | 6 (12.5) | 9 (18.8) | 33 (68.8) | |
- Citation: Shao S, Zhou NM, Dai DQ. Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer. World J Gastroenterol 2019; 25(46): 6713-6727
- URL: https://www.wjgnet.com/1007-9327/full/v25/i46/6713.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i46.6713
